| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Oct―21 |
Long COVID: mechanisms of disease, multisystem sequelae, and prospects for treatment |
Seiya Oba, Tadashi Hosoya, Hideyuki Iwai, Shinsuke Yasuda |
| 2 |
[GO] |
2025―Jul―09 |
Vogt-Koyanagi-Harada syndrome potentially associated with COVID-19 vaccination: a case report and literature review |
Zhiqiang Cui, Yan Luo, Yanli Yi, Xuli Guo, Yuqi Liu, Xiang Wang, Xiaonan Liu |
| 3 |
[GO] |
2024―Apr―17 |
New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review |
Mayumi Matsuda, Yu Funakubo Asanuma, Kyohei Emoto, Sakon Sakai, Nobuhito Okumura, Hiroaki Yazawa, Takashi Maruyama, Takuma Tsuzuki Wada, Kazuhiro Yokota, Yasuto Araki, Yuji Akiyama, Toshihide Mimura |
| 4 |
[GO] |
2024―Apr―15 |
Fetal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case |
Yusuke Ueda, Tomoyuki Sakai, Kazunori Yamada, Kotaro Arita, Yoko Ishige, Daisuke Hoshi, Hiroto Yanagisawa, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Sohsuke Yamada, Akihiro Yachie, Yasufumi Masaki |
| 5 |
[GO] |
2024―Jan―18 |
NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein |
Aiko Murai, Terufumi Kubo, Takayuki Ohkuri, Junko Yanagawa, Yuki Yajima, Akemi Kosaka, Dongliang Li, Toshihiro Nagato, Kenji Murata, Takayuki Kanaseki, Tomohide Tsukahara, Takeshi Nagasaki, Yoshihiko Hirohashi, Hiroya Kobayashi, Toshihiko Torigoe |
| 6 |
[GO] |
2024―Jan―08 |
Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus |
Jun Kikuchi, Yasushi Kondo, Shuichiro Kojima, Shiho Kasai, Yuma Sakai, Masaru Takeshita, Kazuoto Hiramoto, Shuntaro Saito, Hiroyuki Fukui, Hironari Hanaoka, Katsuya Suzuki, Yuko Kaneko |
| 7 |
[GO] |
2023―Mar―23 |
Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination |
Narumichi Iwamura, Katsumi Eguchi, Tomohiro Koga, Kanako Tsutsumi, Takeshi Araki, Toshiyuki Aramaki, Ayuko Takatani, Kaoru Terada, Yukitaka Ueki |
| 8 |
[GO] |
2022―May―27 |
Signaling via dopamine and adenosine receptors modulate viral peptide-specific and T-cell IL-8 response in COVID-19 |
Mieko Tokano, Rie Takagi, Masaaki Kawano, Shigefumi Maesaki, Norihito Tarumoto, Sho Matsushita |
| 9 |
[GO] |
2022―May―03 |
Immunouniverse of SARS-CoV-2 |
Dennis Jiménez, Marbel Torres Arias |
| 10 |
[GO] |
2022―May―01 |
Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review |
Neelam Asghar, Hassan Mumtaz, Abdul Ahad Syed, Farea Eqbal, Reeju Maharjan, Aditya Bamboria, Manish Shrehta |
| 11 |
[GO] |
2021―Dec―17 |
New mimic of relapse or regional lymph node metastasis in a cancer survivor: a case of mRNA COVID-19 vaccine-induced lymphadenitis with high FDG uptake |
Yusuke Tsumura, Koiku Asakura, Ikuko Takahashi, Mitsuko Akaihata, Yoshiyuki Takahashi, Yuji Ishida |
| 12 |
[GO] |
2021―Sep―17 |
Management of inflammatory bowel disease during the COVID-19 pandemic |
Tadakazu Hisamatsu |
| 13 |
[GO] |
2021―Jan―15 |
Immune response to COVID-19 infection: a double-edged sword |
Norma Saad, Salim Moussa |
|
